Drug Profile
YPP 2022
Alternative Names: YPP2022Latest Information Update: 28 Feb 2020
Price :
$50
*
At a glance
- Originator Yungjin Pharm Co
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer; Precocious puberty
Most Recent Events
- 28 Feb 2020 No recent reports of development identified for research development in Cancer in South Korea
- 28 Feb 2020 No recent reports of development identified for research development in Precocious-puberty in South Korea
- 22 Jan 2016 Early research in Cancer in South Korea (unspecified route) prior to January 2016 (Yungjin Pharm's pipeline, January 2016)